Cellectar Biosciences, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Cellectar Biosciences, Inc. (CLRB) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$320.51 thousand for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-08-14
- Cellectar Biosciences, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$254.21K.
- Cellectar Biosciences, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$66.30K.
- Cellectar Biosciences, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$66.99K.
- Cellectar Biosciences, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was -$1.05K.
- Cellectar Biosciences, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$72.25K.
- Cellectar Biosciences, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$58.47K.
- Cellectar Biosciences, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$29.57K, a 101.60% decline from fiscal 2013.
- Cellectar Biosciences, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was $1.85M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 134 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 137 month |
|---|---|---|---|---|---|---|
| 2017-06-30 | -$254.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$320.51K 10-Q · filed 2017-08-14 | -$387.50K derived: sum of 3 quarters · filed 2017-08-14 | -$388.55K derived: sum of 4 quarters · filed 2017-08-14 | ||
| 2017-03-31 | -$66.30K 10-Q · filed 2017-05-11 | -$133.29K derived: sum of 2 quarters · filed 2017-05-11 | -$134.34K derived: sum of 3 quarters · filed 2017-05-11 | -$138.55K derived: sum of 4 quarters · filed 2017-08-14 | ||
| 2016-12-31 | -$66.99K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$68.04K derived: sum of 2 quarters · filed 2017-03-15 | -$72.25K derived: sum of 3 quarters · filed 2017-08-14 | -$72.25K 10-K · filed 2017-03-15 | ||
| 2016-09-30 | -$1.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$5.26K derived: sum of 2 quarters · filed 2017-08-14 | -$5.26K 10-Q · filed 2016-11-10 | -$23.94K derived: sum of 4 quarters · filed 2017-08-14 | ||
| 2016-06-30 | -$4.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$4.21K 10-Q · filed 2017-08-14 | -$22.89K derived: sum of 3 quarters · filed 2017-08-14 | -$29.01K derived: sum of 4 quarters · filed 2017-08-14 | ||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-11 | -$18.68K derived: sum of 2 quarters · filed 2017-05-11 | -$24.80K derived: sum of 3 quarters · filed 2017-05-11 | -$33.00K derived: sum of 4 quarters · filed 2017-05-11 | ||
| 2015-12-31 | -$18.68K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$24.80K derived: sum of 2 quarters · filed 2017-03-15 | -$33.00K derived: sum of 3 quarters · filed 2017-03-15 | -$58.47K 10-K · filed 2017-03-15 | ||
| 2015-09-30 | -$6.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$14.32K derived: sum of 2 quarters · filed 2016-11-10 | -$39.79K 10-Q · filed 2016-11-10 | -$51.96K derived: sum of 4 quarters · filed 2016-11-10 | ||
| 2015-06-30 | -$8.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$33.66K 10-Q · filed 2016-08-11 | -$45.84K derived: sum of 3 quarters · filed 2016-10-20 | -$48.04K derived: sum of 4 quarters · filed 2016-10-20 | ||
| 2015-03-31 | -$25.47K 10-Q · filed 2016-05-12 | -$37.64K derived: sum of 2 quarters · filed 2016-10-20 | -$39.84K derived: sum of 3 quarters · filed 2016-10-20 | -$39.84K derived: sum of 4 quarters · filed 2016-10-20 | ||
| 2014-12-31 | -$12.17K derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-10-20 | -$14.38K derived: sum of 2 quarters · filed 2016-10-20 | -$14.38K derived: sum of 3 quarters · filed 2016-10-20 | -$29.57K 10-K/A · filed 2016-10-20 | ||
| 2014-09-30 | -$2.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$2.21K derived: sum of 2 quarters · filed 2015-11-12 | -$17.40K 10-Q · filed 2015-11-12 | -$30.25K derived: sum of 4 quarters · filed 2015-11-12 | ||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | -$15.19K 10-Q · filed 2015-08-12 | -$28.05K derived: sum of 3 quarters · filed 2015-08-12 | $1.81M derived: sum of 4 quarters · filed 2015-08-12 | ||
| 2014-03-31 | -$15.19K 10-Q · filed 2015-05-20 | -$28.05K derived: sum of 2 quarters · filed 2015-05-20 | $1.81M derived: sum of 3 quarters · filed 2015-05-20 | $1.81M derived: sum of 4 quarters · filed 2015-05-20 | -$4.91M 10-Q · filed 2014-05-14 | |
| 2013-12-31 | -$12.86K derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-20 | $1.82M derived: sum of 2 quarters · filed 2015-05-20 | $1.82M derived: sum of 3 quarters · filed 2015-05-20 | $1.85M 10-K · filed 2015-05-20 | -$4.89M 10-K · filed 2014-03-19 | |
| 2013-09-30 | $1.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-20 | $1.84M derived: sum of 2 quarters · filed 2015-05-20 | $1.87M 10-Q · filed 2015-05-20 | |||
| 2013-06-30 | $28.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $28.79K 10-Q · filed 2014-08-04 | ||||
| 2013-03-31 | $28.76K 10-Q · filed 2014-05-14 | |||||
| 2012-12-31 | -$2.10M 10-K · filed 2014-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |